D2l Clinical Solutions Private Limited, a active private limited company, was established on 15 July 2014 in Bangalore South, Karnataka, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U74900KA2014PTC075357. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shekhar Gupta (Whole-Time Director), Sreya Gupta (Additional Director). Past directors included Marella Ravikant, Shekhar Gupta, Deepak Harikrishnan. It holds no open charges and ₹0.90 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C 41, Skylark Arcadia, Phase 1,, Sadaramangala, K R Puram, Hobli, Bangalore South, Karnataka, 560067.
U74900KA2014PTC075357
075357
15 July 2014
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into D2l Clinical Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shekhar Gupta | Whole-Time Director | 15 Jul 2014 | Current |
| Sreya Gupta | Additional Director | 09 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
D2L Clinical Solutions Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, D2L Clinical Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 May 2020 | Others | ₹0.90 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with D2L Clinical Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of D2L Clinical Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D2L Clinical Solutions's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sreya Gupta was appointed as a Additional Director was appointed as a Additional Director on 09 Oct 2025 & has been associated with this company since 1 month 22 days . was recorded as a recent event.
Progress on D2L Clinical Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on D2L Clinical Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
Progress on A charge registered on 07 May 2020 via Charge ID 100337129 with Others was fully satisfied on 10 Feb 2022. was documented.
The activity A charge with Others amounted to Rs. 0.90 M with Charge ID 100337129 was registered on 07 May 2020. was completed.
Shekhar Gupta was appointed as a Whole-time director was appointed as a Whole-time director on 15 Jul 2014 & has been associated with this company since 11 years 4 months . was recorded as a recent event.
The CIN of D2l Clinical Solutions Private Limited is U74900KA2014PTC075357.
D2l Clinical Solutions Private Limited is headquartered at C 41, Skylark Arcadia, Phase 1,, Sadaramangala, K R Puram, Hobli, Bangalore South, Karnataka, 560067.
D2l Clinical Solutions Private Limited was incorporated on 15 July 2014.
The current directors of D2l Clinical Solutions Private Limited are
The primary industry of D2l Clinical Solutions Private Limited is Hospital And Medical Care.
D2l Clinical Solutions Private Limited is unlisted.
The authorized capital of D2l Clinical Solutions Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of D2l Clinical Solutions Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX